Efficacy and toxicity of lurbinectedin in subsequent systemic therapy of extensive-stage small cell lung cancer: a meta-analysis

Efficacy and toxicity of lurbinectedin in subsequent systemic therapy of extensive-stage small cell lung cancer: a meta-analysis

Abstract Objective This study aimed to systematically analyze the efficacy and toxicity of lurbinectedin as a second-line or subsequent treatment for extensive-stage small cell lung cancer (ES-SCLC). Methods Candidate studies were identified in PubMed, Embase, Cochrane Library, ClinicalTrials.gov, C...

Full description

Bibliographic Details
Main Authors: Jiayi Tang, Tianlei Wang, Hongwei Wu, Xinrui Bao, Ke Xu, Tao Ren
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Cancer
Subjects:
Lurbinectedin
Extensive-stage small cell lung cancer
Efficacy
Toxicity
Meta-analysis
Online Access:https://doi.org/10.1186/s12885-024-13104-w

Internet

https://doi.org/10.1186/s12885-024-13104-w

Similar Items